IE59015B1 - Process for preparing (z)-1-phenyl-1-diethyl amino carbonyl-2-aminomethylcyclopropanehydrochloride - Google Patents

Process for preparing (z)-1-phenyl-1-diethyl amino carbonyl-2-aminomethylcyclopropanehydrochloride

Info

Publication number
IE59015B1
IE59015B1 IE105786A IE105786A IE59015B1 IE 59015 B1 IE59015 B1 IE 59015B1 IE 105786 A IE105786 A IE 105786A IE 105786 A IE105786 A IE 105786A IE 59015 B1 IE59015 B1 IE 59015B1
Authority
IE
Ireland
Prior art keywords
formula
phenyl
process according
reaction
organic solvent
Prior art date
Application number
IE105786A
Other versions
IE861057L (en
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9318686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE59015(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of IE861057L publication Critical patent/IE861057L/en
Publication of IE59015B1 publication Critical patent/IE59015B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1. Process for the industrial preparation of (Z)-1-phenyl-1-diethylaminocarbonyl-2- aminomethylcyclopropane of formula I : see diagramm : EP0200638,P7,F2 characterized by the use of the following successive reaction steps : i) 1-phenyl-2-oxo-3-oxa(3: 1: 0) bicyclohexane of formula II : see diagramm : EP0200638,P8,F1 is opened by treatment with a phthalimide salt in an organic solvent ; ii) (Z)-1-phenyl-2-phthalimidomethylcyclopropane-carboxylic acid of formula III thus obtained see diagramm : EP0200638,P8,F2 is treated with an acid chloride, and then the acid chloride thus formed is amidified by condensation with diethylamine in an organic solvent ; and iii) (Z)-1-phenyl-1-diethylaminocarbonyl-2- phthalimidomethylcyclopropane of formula IV thus obtained : see diagramm : EP0200638,P8,F3 is then treated with an alkylamine or a primary hydroxyalkylamine by itself or in the presence of a solvent to obtain, after hydrochlorination, the compound of abovementioned formula I.

Description

The present invention, carried out at P. F.
MEBICAHEMT Research Centre, relates to a new industrial process for preparing H£DALC£PSAH (international nonpropr ietory name for (2)~1~phenyl-1-diethyla«inocar~ $ T bonyl-2-aminomethylcyclopropane hydrochloride) which corresponds to the formula I: HXDALCXPRAN is currently finding increasing clinical use as ara antidepressant.
In the prior art, illustrated by French Patent A-2,508,035, this compound was prepared according to a S-stage process from 1-phenyl-2"Oxo-3-oxabicycloC3.1.03 hexane, this latter derivative being described in French Patent A=2 ,302,994.
According t© this prior art, the limiting stage of the preparation process occurs at the stage of the reaction of chloride of the l-phenyl-2-aeinoBethylcyclopropane hydrochloride with diethylamine. During this reaction, in effect, a sice reaction takes place, namely an intramolecular cyclization which leads to the formation of a lactam: 1-phenyl"2"Oxo-3-azabicyclo(3.1.Q)" 5901 5 - 2 SCHEME FOR THE EXTRANEOUS SIDE REACTION io Removal s# the lactam requires aft «additional purification, which lowers the yield of M10ALCIPRAH.
The subject of the present invention relates to a new industrial process for preparing HIDALCIPRAN in 3 synthetic stages. It is a feature of this process that, already at the first stage, the amine group is created in a protective form, this thereby enabling the carboxyl group to be activated for the purpose of condensation with diethylamine without a by-product being formed.
The process of the invention can be shown schematically as follows: REACTION SCHEME Ph chai irnids salt ’ GA t (III) (in ISO " 200*C - 3 2nd stage kA ϊ o=c OE (Ill) 3rd stage The first stage of the process consists in condensation of the lactone of formula ΙΪ with a phthalimide salt, in particular potassium phthalimide, in an organic solvent preferably chosen from dimethyIformamide, dimethyI acetaraide and methyIpyrrο Iidone . Th e reaction temperature is preferably between 150 and 200°C, and the reaction time varies from 5 to 15 hours.
During the second stage of the reaction, the IS acid of formula 111 is treated with an acid chloride, in particular thionyl chloride, preferably used in stoichiometric excess. The reaction is advantageously performed by beating under reflux, for a period of between 0.5 and 2 hours. After removal of the thionyl chloride, the acid chloride formed is condensed with - 4 diethyl sm-i π e in an organic solvent, preferably chosen from methylene chloride, chloroform, tetrahydrofuran and dioxane. The temperature of this amidation is advantageously between 5 and 30°C.
During the third stag® of the reaction, the primary amine group is liberated by treating the amide of formula IV with a low molecular weight alkylamine or hydroxy a IkyIaaine, in particular ethanolamine, used alone or in the presence of a solvent such as water or a low molecular weight alcohol (methanol, ethanol, propanol or isopropanol). This reaction is performed at a teassarature between rccm tasperatuxe «aid ths boiling point of ths reaction medium namely, between 60°C and 100°C in the case of hydroxyalky lamine.
After extraction of the reaction medium with a solvent such as methylene chloride, chloroform or ethyl acetate, the residual oil obtained after removal of the solvent is hydrochIorinated, for example using sn ethanolic solution of hydrochloric acid, and the compound of formula I is crystallized by adding ether, isopropyl ether or methylal.
PROCEDURE s t s t a g e (Z)-1Phenyl-2-pht hal im i dome thy I -cyclopropane-1-carjboxylic acid (compound III) A suspension of 52.56 g (0.3 mole) of 1-phenyl2-oxo-3-oxabicycloC3»1-Q)hexane (compound II) and 61 g (0.33 mole) of potassium phthal imide in 270 cm1 of dimethylformamide is maintained with stirring at 1500C for 12 hours.
The solution obtained after the mixture has «L returned to room temperature is poured into 1000 cm of water, iter extraction with ethyl acetate, the aqueous phase is acidified with an excess of acetic acid and then cooled in ice. The acid which crystallizes is drained, washed with water and recrystallized in ethanol to give 62.6 g of compound III (yields 65X).
Melting point: 186° Formula: C-joH -)5^04: 321.22 TLC (Merck silica GF 254) Rf: 0-6 (chloroform/methanol 85:15) IR: (KBr) 0 c=0: 1775, 1710 and 1650 cm11H NMR (CDCI3) δ ppm (TMS): 1.1 to 2 (m, 3H, cyclopropane); 3-9 (0, 2H, CHjjN); 7. 1S (s, 5H, aromatic); 7.75 (s, 4H, aromatic). 2nd stage (Z) " 1 - P h eny I -1 -d i et h y I am i noc a rbony l-2-phthal imidomathyleyclopropgne (compound IV) 16.2 g (0.05 mole) of 1 -phenyL-2-phtha Iiraidome thyIcyc I opropane- 1 -carboxyIic acid (compound III) are 3 added to 30 cm of thionyl chloride at room temperature with stirring. Dissolution is complete after 2 hours at room temperature.
The solution is then maintained under reflux for hours- After removal of the excess thionyl chloride, the crude acid chloride, dissolved in 50 cm of methylene chloride, is introduced dropwise into a solution of 10.3 ca° (0.1 mole) of diethylamine and 150 caJ of methylene chloride with stirring in an ieebath. After the mixture has been left overnight with stirring at room temperature, the solution obtained is washed with water, dried over filtered and concentrated under reduced pressure. On addition of isopropyl ether, 15„4 g of compound IV are obtained (yield: 82*)» Melting point: 13 Ί0 Formula: ^23^24^2θ3 376.46 TLC (Merck silica GF 254); Rf = 0.66 (chloroform/methanol 95:5) IR (KBr) ti C = 0 1630, 1705 and 1770 cm NMR (CDCI3) δ PPia (TMS): 0.65 (t, 5H, CH3); 1.15 (t, 3H , C H3 ) ; 1.25 ( m, IH, cyclopropane); 1.5-2.3 (m, 2H, cyclopropane); 3-3.7 (m, 5H, CHjN, cyclo-CH-N); 4.15 (dd, IH, cycIo-CH-N); 7.1 (s, 5H, aromatic); 7.6 (m, 4Η, aromatic). 3rd stage (Z)-1-Phenyl-l-diethylaminocarbonyl-2-am i nome thy I eye 10 propane hydrochloride (compound I), MIDALCIPRAH a) The suspension of 18.82 g (0.05 mole) of 1-phenyl-1-diethylaminocarbonyl-2-phthaliraidoraethylcyclopropane (compound IV) in 95 cm of a 40* strength aqueous solution of me thy I amine is maintained with stirring at rooc temperature for 5 hours.
Dissolution takes place, followed by crystallization of N,N-d 1 methyI phtha I amide. The suspension is extracted 3 times with ethyl acetate. The organic phase is washed with water, dried over Nap SO/, and filtered, and the solvent is resovec under the addition of an ethanolic acid followed by ether, 10 g I are obtained (yield: 7IX) reduced pressure. After solution of hydrochloric of crystals of the comoound - Ί - Melting points 18 0 0 Formula: C15H23CIN2G: 282.82 TLC (Merck silica GF 245) S Rf: 0.43 (chloroform /methanol/NH4OH 84:14:2) IR (KBr ) ΐ 4 C-.Q 1010 ca11H NMR (D2Q) δ ppm (TSP) 0.8 (t, 3H„ CH3); 1.15 (t 3H, CH3); 1.5-2.1 (m, 3H, cyclopropane); 3-3.7 (ra, CHjN); 7.3 (s, aromatic). b) The suspension of 60 g (0.159 mole) of 1-phenyl· 1~diethyla»inocarbonyl-2-phthalimidomethylcyclopropane in 60 cra^ of ethanolaraine is maintained for 1 hour at 90°C with stirring.
After addition of 300 ral of ice-cold water, the mixture is extracted 3 times with ethyl acetate.
The organic phase is washed with water, dried over Na^SOt and filtered, and the solvent is removed under reduced pressure.
After addition of a 5N ethanolic solution of hydrochloric acid followed by ether, 39.7 g of crystals of the compound I are obtained (yield; 88%) Melting point: 178 -

Claims (11)

1. Process for the industrial preparation of (
2. )-1phenyl-1-diethyl9rainocarbonyl -2 -asainoisethylcy clo propane hydrochloride of formula I: characterised by the use of the following successive reac tion steps: i) 1-phenyl-2-oxo-3-oxaC3;1:0)bicyclohexane of is opened by treatment with a phthalinide salt in an organic solvent; i i5 (I)-1-pheny l-2-pfotfoalinidosethyI eyelopropanecarboxylic acid of foreula Eli thus obtained chloride thus formed is amidified by condensation with diethylamine in an organic solvent; and iii) (Z3“1-phenyl“1“diethylatftinocarbonyl“2“phthaI iaidoaethyI cyclopropane of formula IV thus obtained: IV is then treated with an elkylaaine or a primary hydroxyalkylamine by itself or in the presence of a solvent to obtain, after hydrochlorination, the compound of abovementioned forsula ΧΙΟ 2.. Process according to Claim 1, characterized in that the phthalimide salt employed is potassium phthal imide»
3., Process according to (either of Cla ias 1 arid 2, characterized in that the treatment of the lactone of 15 formula II with the phthalimide salt is performed in an organic solvent chosen from dimethyI formamide, dimethylacetamide and methylpyrrolidone.
4. „ Process according to one of Claims 1 to 3, characterized in that the first step of condensation of 20 the phthal imide salt with the lactone of formula 2Z is performed at a reaction temperature situated in the range of the boiling points ©f the solvent employed during this step, preferably between 1SO ! °C and 200°'c„ »
5. Process according to one of Claims 1 to 4, charac· in that the acid chloride «splayed during the step is thionyl chloride. according to one of Claims 1 to 5, characthe treatment of the compound of formula XXI with the acid chloride is performed by heating under 30 reflux,, 7. Process according to one of Claims 1 to 6, characterised in that the acidification of the second reaction t e r ι x« second reaction
6. „ Process terized in that step is performed in an organic solvent chosen from aethylen© chloride, chloroform, tetrahydrofuran and dioxane.
7. 8. Process according to one of Cl a ias 1 to 7, characterised in that the reaction teaperature of the an id if i5 cation in the second step is between 5°C and 30°C.
8. 9. Process-according to one of Claims 1 to 8, characterised in that the primary aa ine eaployed during the third reaction step is ethanolaaine.
9. 10- Process according to one of Claims 1 to 9, charac10 terised in that the final hydrochlorination is effected with the aid of an ethanolic solution of hydrochloric acid.
10. 11. A process according to dais 1 for the industrial preparation of (Z)-l-phenyl-l-diethylaninocarbonyl~2~aaino15 methylcyclopropane hydrochloride of the formula I given in Claim 1,. substantially as hereinbefore described and exemplified.
11. 12 e (z) -l-Phenyl-i-diethylaminocarbonyl'-2->aainomethyl“ 20 cyclopropane hydrochloride of the formula I given in Claim 1 whenever prepared by a process claimed in a preceding claim.
IE105786A 1985-04-25 1986-04-21 Process for preparing (z)-1-phenyl-1-diethyl amino carbonyl-2-aminomethylcyclopropanehydrochloride IE59015B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8506335A FR2581059B1 (en) 1985-04-25 1985-04-25 PROCESS FOR THE PREPARATION OF PHENYL-1 HYDROCHLORIDE DIETHYL AMINO CARBONYL-1 AMINOMETHYL-2 CYCLOPROPANE (Z)

Publications (2)

Publication Number Publication Date
IE861057L IE861057L (en) 1986-10-25
IE59015B1 true IE59015B1 (en) 1993-12-15

Family

ID=9318686

Family Applications (1)

Application Number Title Priority Date Filing Date
IE105786A IE59015B1 (en) 1985-04-25 1986-04-21 Process for preparing (z)-1-phenyl-1-diethyl amino carbonyl-2-aminomethylcyclopropanehydrochloride

Country Status (23)

Country Link
EP (1) EP0200638B1 (en)
JP (1) JPS61251650A (en)
KR (1) KR940006764B1 (en)
AR (1) AR240695A1 (en)
AT (1) ATE42273T1 (en)
AU (1) AU587613B2 (en)
CA (1) CA1266486A (en)
DE (1) DE3662877D1 (en)
DK (1) DK170888B1 (en)
ES (1) ES8704449A1 (en)
FI (1) FI87196C (en)
FR (1) FR2581059B1 (en)
GE (1) GEP19970789B (en)
GR (1) GR860980B (en)
HU (1) HU195182B (en)
IE (1) IE59015B1 (en)
MX (1) MX162896B (en)
NO (1) NO165143C (en)
OA (1) OA08241A (en)
PT (1) PT82461B (en)
SU (1) SU1443797A3 (en)
YU (1) YU44915B (en)
ZA (1) ZA862929B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640972B1 (en) * 1988-12-28 1991-04-19 Pf Medicament
US5621142A (en) * 1994-02-22 1997-04-15 Asahi Kasei Kogyo Kabushiki Kaisha Aminoalkylcyclopropane derivatives
FR2752732B1 (en) * 1996-08-28 1998-11-20 Pf Medicament EXTENDED RELEASE GALENIC FORM OF MILNACIPRAN
JP4418717B2 (en) * 2004-06-24 2010-02-24 住友化学株式会社 Process for producing (Z) -1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane hydrochloride
JP4828863B2 (en) 2005-01-28 2011-11-30 住友化学株式会社 Process for producing (Z) -1-phenyl-1- (N, N-diethylaminocarbonyl) -2-phthalimidomethylcyclopropane
EP1894565B1 (en) 2005-06-10 2013-10-30 Pierre Fabre Médicament S.A. Stabilized milnacipran formulation
KR100772244B1 (en) * 2005-07-20 2007-11-01 안국약품 주식회사 Method for the preparation of milnacipran hydrogen chloride salt
CN101415677B (en) * 2006-04-17 2012-05-23 住友化学株式会社 Method for producing polycyclic lactam compounds
JP5338035B2 (en) * 2006-04-17 2013-11-13 住友化学株式会社 Process for producing polycyclic lactams
WO2008104957A2 (en) * 2007-02-28 2008-09-04 Ranbaxy Laboratories Limited Novel polymorphic forms of milnacipran hydrochloride
FR2941454B1 (en) 2009-01-29 2011-04-01 Pf Medicament PROCESS FOR THE SYNTHESIS OF (1S, 2R) -MILNACIPRAN
US20100274050A1 (en) * 2009-04-23 2010-10-28 Glenmark Generics Limited Solid milnacipran and process for the preparation of the same
EP2699539B1 (en) 2011-04-21 2019-03-06 Emory University Cyclopropyl derivatives and methods of use
CN103242289B (en) * 2012-02-03 2015-01-07 暨明医药科技(苏州)有限公司 Preparation method of N,N-diallyl-(1R,2R)-2-aminomethyl-1-(2-thienyl)cyclopropanecarboxamide hydrochloride
WO2014009767A1 (en) 2012-07-07 2014-01-16 Micro Labs Limited An improved process for the preparation of 1-aryl 2-aminomethyl cyclopropane carboxyamide (z) derivatives, their isomers and salts
WO2014058744A2 (en) 2012-10-09 2014-04-17 California Institute Of Technology In vivo and in vitro olefin cyclopropanation catalyzed by heme enzymes
FR2998892B1 (en) * 2012-12-04 2015-01-02 Pf Medicament AMINOCYCLOBUTANE DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR USE AS MEDICAMENTS
CN103613513B (en) * 2013-12-09 2016-01-20 上海现代制药股份有限公司 Milnacipran hydrochloride intermediate and its preparation method and application
US9399762B2 (en) 2014-02-18 2016-07-26 California Institute Of Technology Methods and systems for sulfimidation or sulfoximidation of organic molecules
CN104058992A (en) * 2014-06-13 2014-09-24 上海现代制药股份有限公司 Crystal form of levomilnacipran hydrochloride
EP3230258B1 (en) 2014-11-04 2019-06-26 Química Sintética, S.A. Process for the preparation of (1s,2r)-milnacipran

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508035A1 (en) * 1981-06-23 1982-12-24 Fabre Sa Pierre ARYL-1-AMINOMETHYL-2 CYCLOPROPANES CARBOXAMIDE (Z) DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Also Published As

Publication number Publication date
IE861057L (en) 1986-10-25
AR240695A1 (en) 1990-09-28
OA08241A (en) 1987-10-30
KR860008126A (en) 1986-11-12
FR2581059A1 (en) 1986-10-31
GEP19970789B (en) 1997-01-28
FI87196C (en) 1992-12-10
ES554321A0 (en) 1987-04-01
YU44915B (en) 1991-04-30
KR940006764B1 (en) 1994-07-27
PT82461A (en) 1986-05-01
HU195182B (en) 1988-04-28
HUT40618A (en) 1987-01-28
EP0200638A1 (en) 1986-11-05
FR2581059B1 (en) 1988-04-22
MX162896B (en) 1991-07-08
CA1266486A (en) 1990-03-06
NO165143B (en) 1990-09-24
DK170888B1 (en) 1996-03-04
ATE42273T1 (en) 1989-05-15
NO861573L (en) 1986-10-27
GR860980B (en) 1986-08-25
DE3662877D1 (en) 1989-05-24
JPH0567136B2 (en) 1993-09-24
SU1443797A3 (en) 1988-12-07
DK191286D0 (en) 1986-04-24
ES8704449A1 (en) 1987-04-01
JPS61251650A (en) 1986-11-08
YU65586A (en) 1987-12-31
DK191286A (en) 1986-10-26
AU587613B2 (en) 1989-08-24
AU5634386A (en) 1986-10-30
FI861755A (en) 1986-10-26
ZA862929B (en) 1986-12-30
NO165143C (en) 1991-01-09
FI87196B (en) 1992-08-31
FI861755A0 (en) 1986-04-25
EP0200638B1 (en) 1989-04-19
PT82461B (en) 1988-10-14

Similar Documents

Publication Publication Date Title
IE59015B1 (en) Process for preparing (z)-1-phenyl-1-diethyl amino carbonyl-2-aminomethylcyclopropanehydrochloride
SU628812A3 (en) Organic compound producing method
FI81338B (en) 4- / 4- (DIMETHYLAMINO) -1- (4'-FLUORPHENYL) -1-HYDROXIBUTYL / -3- (HYDROXIMETHYL) BENZONITRILE FORM FARING FRAMSTATING WITH DENNA OCH DESS ANVAENDNING VID FRAMSTAELLING AV 1- (3-DIMING) (4'-FLUORPHENYL) -1,3-DIHYDROISOBENSOFURAN-5-CARBONITRIL.
PL203275B1 (en) Method for the preparation of 5-cyanophthalide
US20090012313A1 (en) 3-Carboxy-2-Oxo-1-Pyrrolidine Derivatives and Their Uses
US3153092A (en) 1-methyl-2-phenylcyclopropylamine derivatives
SE449358B (en) PROCEDURE FOR THE PREPARATION OF 4-AMINOHEX-5-ACID ACID OR SALTS THEREOF
EP0179254A1 (en) 4,5-Dihydro-4-oxo-2- [(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof
KR20030014619A (en) A process for the preparation of high purity Pemirolast
KR20010076278A (en) 3-(1-Hydroxy-Pentylidene)-5-Nitro-3H-Benzofuran-2-One, a Process for the Preparation thereof and the Use thereof
AU744272B2 (en) Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
JPH0524158B2 (en)
NO771771L (en) PROCEDURES FOR THE PREPARATION OF NEW DERIVATIVES OF DIBENZO (DE, H) QUINOLINE
US4029647A (en) Synthesis of biotin
IE41999B1 (en) Preparation of 6,11-dihydro-11-oxodiben(b,e)-oxepin-alkanoic acids
US4559178A (en) Resolution of 3-benzoylthio-2-methyl-propanoic acid with (+)-dehydroabietylamine
US4595755A (en) 5-halo-1,2,3-(1,2-dihydropyrrolo)-4-quinolones
NO162019B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIMIDOISKINOLIN DERIVATIVES.
PL172906B1 (en) Method of obtaining indobufene in pharmaceutically advantageous crystalline form
FI76782B (en) AMID INNEHAOLLANDE D-2- (6-METOXY-2-NAFTYL) -PROPIONSYRANS KINCONIDINSALT OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
EP0437567B1 (en) Phenyl-glycine derivatives
SI8610655A8 (en) Process for preparation of 1-phenyl-1-diethylaminocarbonyl-2- aminomethyl-cyclopropanhydrochloride
FI64348C (en) FOERFARANDE FOER UPPDELNING AV EN BLANDNING AV D- OCH 1-2- (6-METOXY-2-NAPHTHYL) -PROPIONSYROR I OPTICAL ACTIVE ISOMER
GB2376945A (en) Citalopram preparation
JPH0383969A (en) Production of indole-3-carbonitrile compound

Legal Events

Date Code Title Description
MK9A Patent expired